Researchers believe psilocybin could be a powerful tool to not only extend lifespan but also improve the quality of life in older adults.

For the new study, scientists at Emory University and Baylor College of Medicine in the US tested it on cultures of human ...

A natural compound found in psychedelic mushrooms might help people live longer and age more slowly, according to new research from Emory University. Scientists have discovered that psilocin, which ...

To date, more than 150 clinical studies have been completed or are ongoing for examining psilocybin in the treatment of ...

Psilocybin improved longevity and health markers in mice and cells. The findings reveal unexpected systemic benefits. As the ...

Emory University researchers discovered that psilocin, derived from magic mushrooms, significantly extends lifespan and ...

Psilocybin shows potential as an anti-aging drug, extending lifespan and improving cellular health in new studies.

A surprising discovery from Emory University shows that psilocin, the active metabolite of psychedelic mushrooms, can delay ...

Tryptamine Therapeutics has kicked off patient recruitment for its world-first psilocin trial targeting Binge Eating Disorder ...

With no clear rules from health or drug authorities, thousands of businesses openly sell psilocybin mushrooms even though the ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a clinical-stage neuropsychiatry company, announced UK MHRA approval to initiate EMBRACE, the second pivota ...

Detailed price information for Lobe Sciences Ltd (LOBE-CN) from The Globe and Mail including charting and trades.